Tech Company Financing Transactions

Scout Bio Funding Round

On 4/11/2019, Scout Bio announced $20 million in Series B funding from Companion Fund, RiverVest Venture Partners and Adage Capital Management.

Transaction Overview

Company Name
Announced On
4/11/2019
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 N 18th St. 300
Philadelphia, PA 19103
USA
Email Address
Not Recorded
Overview
Scout Bio, a Philadelphia, PA-based biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions.
Profile
Scout Bio LinkedIn Company Profile
Social Media
Scout Bio Company Twitter Account
Company News
Scout Bio News
Facebook
Scout Bio on Facebook
YouTube
Scout Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Heffernan
  Mark Heffernan LinkedIn Profile  Mark Heffernan Twitter Account  Mark Heffernan News  Mark Heffernan on Facebook
Chief Financial Officer
Damian Lismore
  Damian Lismore LinkedIn Profile  Damian Lismore Twitter Account  Damian Lismore News  Damian Lismore on Facebook
Vice President
Jodi Hayes
  Jodi Hayes LinkedIn Profile  Jodi Hayes Twitter Account  Jodi Hayes News  Jodi Hayes on Facebook
VP - Bus. Development
Samantha Busfield
  Samantha Busfield LinkedIn Profile  Samantha Busfield Twitter Account  Samantha Busfield News  Samantha Busfield on Facebook
VP - Bus. Development
Colin Giles
  Colin Giles LinkedIn Profile  Colin Giles Twitter Account  Colin Giles News  Colin Giles on Facebook
VP - Manufacturing
Jaysson Eicholtz
  Jaysson Eicholtz LinkedIn Profile  Jaysson Eicholtz Twitter Account  Jaysson Eicholtz News  Jaysson Eicholtz on Facebook
VP - Product Management
Matthew Wilson
  Matthew Wilson LinkedIn Profile  Matthew Wilson Twitter Account  Matthew Wilson News  Matthew Wilson on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/11/2019: EdiGene venture capital transaction
Next: 4/11/2019: Re Botanicals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary